CATALOGO DEI PRODOTTI DELLA RICERCA

BERTOLDO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.315
EU - Europa 7.530
AS - Asia 5.702
SA - Sud America 862
Continente sconosciuto - Info sul continente non disponibili 169
AF - Africa 153
OC - Oceania 15
Totale 22.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.179
RU - Federazione Russa 2.366
SG - Singapore 2.286
GB - Regno Unito 1.998
CN - Cina 1.652
IT - Italia 867
BR - Brasile 693
VN - Vietnam 505
HK - Hong Kong 462
SE - Svezia 442
FR - Francia 414
DE - Germania 413
FI - Finlandia 350
IE - Irlanda 324
KR - Corea 180
BD - Bangladesh 120
UA - Ucraina 113
IN - India 94
TR - Turchia 84
ID - Indonesia 66
AR - Argentina 59
CA - Canada 58
NL - Olanda 52
JP - Giappone 44
NG - Nigeria 43
MX - Messico 39
AE - Emirati Arabi Uniti 35
ZA - Sudafrica 34
EC - Ecuador 27
IQ - Iraq 27
ES - Italia 26
PK - Pakistan 21
PL - Polonia 21
BE - Belgio 19
CL - Cile 19
RO - Romania 18
VE - Venezuela 17
AT - Austria 16
PH - Filippine 16
CO - Colombia 15
EG - Egitto 15
EE - Estonia 13
AU - Australia 12
CZ - Repubblica Ceca 12
IR - Iran 12
LT - Lituania 12
MY - Malesia 12
PY - Paraguay 12
MA - Marocco 10
UZ - Uzbekistan 10
BJ - Benin 9
CR - Costa Rica 9
JO - Giordania 9
KE - Kenya 9
DZ - Algeria 8
IL - Israele 8
JM - Giamaica 8
OM - Oman 8
HR - Croazia 7
PE - Perù 7
PR - Porto Rico 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
SA - Arabia Saudita 6
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
TG - Togo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
CH - Svizzera 4
GA - Gabon 4
HN - Honduras 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
RS - Serbia 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IS - Islanda 3
MM - Myanmar 3
PT - Portogallo 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
GR - Grecia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BS - Bahamas 1
Totale 22.556
Salva come PNG Salva come JPEG
Città #
Southend 1.775
Singapore 1.207
Jacksonville 981
Chandler 816
Ashburn 755
San Jose 749
Moscow 698
Dallas 608
Hong Kong 450
Ann Arbor 388
Woodbridge 377
Houston 326
Dublin 321
Council Bluffs 287
Verona 279
Beijing 220
The Dalles 193
Ho Chi Minh City 166
New York 156
Princeton 149
Lawrence 148
Los Angeles 137
Wilmington 137
Nanjing 124
Hanoi 110
Jinan 109
Shenyang 97
Milan 96
Buffalo 87
Helsinki 76
Hebei 74
Changsha 69
Sindelfingen 69
Boardman 68
Tianjin 67
Santa Clara 66
São Paulo 63
Munich 54
Nanchang 53
Redondo Beach 51
Orem 49
Ningbo 48
Bologna 46
Zhengzhou 41
Abuja 40
London 40
Tokyo 40
Taizhou 36
Haikou 35
Jakarta 35
Rome 34
Hangzhou 33
Jiaxing 33
Chicago 32
San Francisco 32
Columbus 28
Da Nang 28
Dearborn 27
Guangzhou 26
Lancaster 24
Frankfurt am Main 23
Phoenix 22
Rio de Janeiro 22
Montreal 21
Atlanta 20
Falls Church 19
Johannesburg 19
Seoul 19
Turku 19
Haiphong 18
Norwalk 18
Amsterdam 17
Brooklyn 17
Denver 17
Fuzhou 17
Mexico City 17
Paris 17
Brussels 16
Chennai 16
Detroit 16
Dong Ket 16
Stockholm 16
Taiyuan 16
Belo Horizonte 15
Boston 15
Curitiba 15
Lappeenranta 15
Seattle 15
Warsaw 15
Biên Hòa 14
Mumbai 14
Dhaka 13
Florence 13
Manchester 13
Redmond 12
Washington 12
Brasília 11
Fairfield 11
Falkenstein 11
Lanzhou 11
Totale 14.006
Salva come PNG Salva come JPEG
Nome #
Adipocytes IGFBP-2 expression in prepubertal obese children. 342
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. 283
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 274
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells 262
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 258
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 248
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 246
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells 244
Age-related bone loss in postmenopausal women 239
STEAP mRNA detection in serum of patients with solid tumours. 238
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 236
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 235
Bone metabolism in patients with anorexia nervosa and amenorrhoea 228
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 221
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 218
BISPHOSPHONATES DECREASE HTERT IN PC3 AND DU-145 PROSTATE CANCER CELLS 216
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus Deflazacort. 214
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 205
Incidenza di ipovitaminosi D nel Nord Italia 199
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020 199
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 198
Histomorphometric analysis of glucocorticoid-induced osteoporosis 194
Altered bone metabolism in children infected with human immunodeficiency virus. 192
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 192
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 192
Bone development during GH and GnRH analog treatment 190
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 190
Bone microarchitecture evaluated by histomorphometry 187
Guidelines for the diagnosis, prevention and management of osteoporosis 182
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 181
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? 180
Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ) 179
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic 176
Blood ionized calcium is associated with clustered polymorphism in the carboxyl-terminal tail of the calcium-sensing receptor. 174
ARTROPATIE DISMETABOLICHE 172
Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. 172
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 168
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 167
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 166
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 165
Bisfosfonati e metastasi ossee:up-to-date 2005 165
Bone Microarchitecture in Mild Primary Hyperparathyroidism 163
emerging drugs for the management of cancer treatment induced bone loss 162
[Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project] 159
Artropatie dismetaboliche 158
Osteopenia induced by immunosuppressive drugs in rats. Histomorphometric analisys of risedronate effects. 157
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 157
GAPDH: CONSTITUTIVE HOUSEKEEPING GENE OR TARGET FOR THERAPEUTIC INTERVENTION? 156
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. 155
The renal handling of calcium: influence of parathyroid hormone secretion 153
Effects of a 4400 km ultra-cycling non-competitive race and related training on body composition and circulating progenitors differentiation 152
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. 152
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 152
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) 152
Drug-induced osteonecrosis of the jaw: the state of the art 152
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 151
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 151
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy 150
Biology and Pathophysiology of Bone Metastasis in Prostate Cancer 150
YEARS BOOK 2006 . BISFOSFONATI E ONCOLOGIA 146
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 144
Osteomalacia: The missing link in the pathogenesis of Bisphosphonate-related osteonecrosis of the jaws? 144
Incidenza di ipovitaminosi D nel Nord Italia 143
PEAK BONE MASS AND BODY COMPOSITION IN PRECOCIOUS PUBERTY AFTER GNRH AGONIST THERAPY WITH AND WITHOUT CALCIUM SUPPLEMENTATION 143
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 142
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 142
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 141
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 140
CALCIUM SUPPLEMENTATION, OESTROGENS AND BONE DENSITY IN GNRHA TREATED PRECOCIOUS PUBERTY 140
EFFETTO DI UN AGONISTA DEL GNRH AD AZIONE PROLUNGATA (LEUPROLIDE ACETATO) SULLO STATO DI MINERALIZZAZIONE OSSEA IN BAMBINE CON PUBERTA' PRECOCE 138
Valutazione della microarchitettura ossea nell'iperparatiroidismo primitivo 138
Bone mineral density and metabolism in HIV-infected children 137
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 137
Physiopatology of bone metastases 137
The prevention of corticosteroid-induced osteoporosis with nandrolone decantate Bone and Mineral 15, 72-81 (1991) 136
Transdermal Estradiol in the treatment of postmenopausale bone loss. 135
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 135
The use of dichloromethylene bisphosphonate and aminobutanebisphosphonate in hypercalcemia of malignancy. 134
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 133
Transdermal estradiol in the treatment of postmenopausal bone loss. 130
The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study 130
Final peak bone mass in precocious puberty after GhRH agonist therapy with and without calcium supplementation 128
Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools. 128
The Effect of Bisphosphonates on Gene Expression: The GAPDH as a Housekeeping or a New Target Gene? 127
Sodium requirements regulates renal tubular reabsorption of calcium 127
Calcium Supplementation Increases Bone Mass in GH-Deficient Prepubertal Children during GH Replacement 127
Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone. 127
Serum 25-hydroxy vitamin D and exercise capacity in COPD. 127
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiopathic hypercalcemia and with primary hyperparathyroidism 126
Effetto dell'alendronato sulle caratteristiche strutturali e biomeccaniche dell'osso corticale 125
intramuscolar neridronate in postmenopausal women with low bone mineral density 125
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary 124
Ruolo dei bisfosfonati nella terapia dell'osteoporosi 123
A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis 123
Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options. 121
HIV-infected children and bone mineral density 120
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiophatic hypercalciuria and primary hyperparathyroidism 120
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 120
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteopororis fractures 119
The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists 119
Totale 16.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.084
article - articoli 69.155
book - libri 1.280
conference - conferenze 3.835
curatela - curatele 0
other - altro 271
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.543
Totale 156.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.155 0 389 6 101 48 48 14 61 39 27 122 300
2022/20232.308 218 196 274 364 227 524 12 134 240 24 73 22
2023/20241.191 53 89 131 135 170 169 59 74 7 50 159 95
2024/20253.153 188 199 113 478 170 75 182 184 461 228 213 662
2025/20268.622 640 469 763 1.356 2.035 550 813 493 759 401 172 171
2026/2027551 213 338 0 0 0 0 0 0 0 0 0 0
Totale 22.746